Baliopharm / Strategy

Baliopharm focuses on the development of innovative protein therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Morbus Crohn and multiple sclerosis. It is the intention of Baliopharm to develop it drug candidates at a maximum up to Phase II proof of concept in patients and to partner afterwards. For smaller indications and selected markets, Baliopharm may develop its drug candidates up to market launch.